Increasing Incidence of Kaposi's Sarcoma in Black South Africans in KwaZulu-Natal, South Africa (1983-2006)
Overview
Affiliations
The aim of the study was to describe the temporal trends in the incidence of Kaposi's sarcoma (KS) in black South Africans in KwaZulu-Natal (KZN). The study was designed as a retrospective record review. The incidence of Kaposi's sarcoma was estimated using administrative records for patients receiving care for KS through public sector oncology clinics in KZN, 1983-2006. Annual age-standardized incidence rates were calculated using provincial census data for the denominator. Age-specific rates were calculated for the pre-AIDS (1983-1989) and for the generalized AIDS epidemic eras (2006). Age-standardized incidence of KS increased in KZN from <1:100,000 in 1990 to at least 15:100,000 in 2006; this increase was observed in both men and women. There was a shift in the peak age-specific incidence rates from the sixth decade of life in the pre-AIDS era to the fourth and fifth decades in the AIDS era. In conclusion, KS is a growing public health problem in KZN, South Africa. These data reinforce the need for comprehensive national access to and roll-out of antiretroviral drugs, given their success in prevention and treatment of KS in first-world settings.
Skin Cancer in People of Color: A Systematic Review.
Zakhem G, Pulavarty A, Lester J, Stevenson M Am J Clin Dermatol. 2021; 23(2):137-151.
PMID: 34902111 DOI: 10.1007/s40257-021-00662-z.
'RNA circles of influence' in Kaposi sarcoma.
Tsitsipatis D, Gorospe M Ann Transl Med. 2019; 7(Suppl 3):S109.
PMID: 31576316 PMC: 6685872. DOI: 10.21037/atm.2019.05.17.
Discovery of Kaposi's sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA.
Tagawa T, Gao S, Koparde V, Gonzalez M, Spouge J, Serquina A Proc Natl Acad Sci U S A. 2018; 115(50):12805-12810.
PMID: 30455306 PMC: 6294913. DOI: 10.1073/pnas.1816183115.
Shaik F, Uldrick T, Esterhuizen T, Mosam A J Glob Oncol. 2018; 4:1-9.
PMID: 30354935 PMC: 6818281. DOI: 10.1200/JGO.18.00105.
Busakhala N, Waako P, Strother M, Keter A, Kigen G, Asirwa F J Glob Oncol. 2018; 4:1-9.
PMID: 30241150 PMC: 6223418. DOI: 10.1200/JGO.17.00077.